糖皮质激素剂量依赖性对人声带成纤维细胞和巨噬细胞基因表达的影响
本研究为体外实验,用人声带成纤维细胞和THP-1单核细胞来源的人巨噬细胞,分别用0.03-1000 nM地塞米松、0.3-10000 nM甲泼尼龙和0.3-10000 nM曲安奈德联合干扰素-γ、肿瘤坏死因子-α或白细胞介素-4处理,用实时聚合酶链反应分析炎症与纤维化基因及TSC22D3表达,并计算EC50与IC50。结果显示糖皮质激素降低炎症基因表达,对纤维化相关基因仅中度诱导,各糖皮质激素上调CCN2的EC50高于下调其他基因的IC50。
要点
- 干扰素-γ和肿瘤坏死因子-α升高两种细胞的炎症基因表达,糖皮质激素可降低该反应
- 白细胞介素-4升高巨噬细胞LOX和TGM2表达,糖皮质激素亦可降低该反应
- 各糖皮质激素上调CCN2的EC50高于下调其他基因的IC50
核心结论
- 较低浓度糖皮质激素抑制炎症基因表达,仅中度诱导参与纤维化的基因。
- 作者认为这些数据值得考虑作为优化临床治疗范式的基础,以减少炎症并减轻纤维化。
研究设计与样本
- 体外研究:人声带成纤维细胞与THP-1单核细胞来源的人巨噬细胞。
- 地塞米松0.03-1000 nM、甲泼尼龙0.3-10000 nM、曲安奈德0.3-10000 nM,联合干扰素-γ、肿瘤坏死因子-α或白细胞介素-4处理。
- 实时聚合酶链反应分析炎症基因(CXCL10、CXCl11、PTGS2、TNF、IL1B)、纤维化基因(CCN2、LOX、TGM2)及糖皮质激素信号靶基因TSC22D3,并计算EC50与IC50。
主要发现
- 干扰素-γ和肿瘤坏死因子-α升高两种细胞的炎症基因表达,糖皮质激素降低该反应。
- 白细胞介素-4升高巨噬细胞LOX和TGM2表达,糖皮质激素亦降低该反应。
- 糖皮质激素诱导TSC22D3和CCN2表达,且不依赖细胞因子处理。
- 各糖皮质激素上调CCN2的EC50高于下调其他基因的IC50。
临床怎么用
- 原文未据此给出临床推荐。
- 作者认为这些数据值得考虑作为优化临床治疗范式的基础,以减少炎症并减轻纤维化。
局限性
- 原文在结论中提出需进一步考虑这些数据作为优化临床治疗范式的基础。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Glucocorticoids (GCs) modulate multiple cellular activities including inflammatory and fibrotic responses. Outcomes of GC treatment for laryngeal disease vary, affording opportunity to optimize treatment. In the current study, three clinically employed GCs were evaluated to identify optimal in vitro concentrations at which GCs mediate favorable anti-inflammatory and fibrotic effects in multiple cell types. We hypothesize a therapeutic window will emerge as a foundation for optimized therapeutic strategies for patients with laryngeal disease. STUDY DESIGN: In vitro. METHODS: Human vocal fold fibroblasts and human macrophages derived from THP-1 monocytes were treated with 0.03-1000 nM dexamethasone, 0.3-10,000 nM methylprednisolone, and 0.3-10,000 nM triamcinolone in combination with interferon-γ, tumor necrosis factor-α, or interleukin-4. Real-time polymerase chain reaction was performed to analyze inflammatory (CXCL10, CXCl11, PTGS2, TNF, IL1B) and fibrotic (CCN2, LOX, TGM2) genes, and TSC22D3, a target gene of GC signaling. EC50 and IC50 to alter inflammatory and fibrotic gene expression was calculated. RESULTS: Interferon-γ and tumor necrosis factor-α increased inflammatory gene expression in both cell types; this response was reduced by GCs. Interleukin-4 increased LOX and TGM2 expression in macrophages; this response was also reduced by GCs. GCs induced TSC22D3 and CCN2 expression independent of cytokine treatment. EC50 for each GC to upregulate CCN2 was higher than the IC50 to downregulate other genes. CONCLUSION: Lower concentrations of GCs repressed inflammatory gene expression and only moderately induced genes involved in fibrosis. These data warrant consideration as a foundation for optimized clinical care paradigms to reduce inflammation and mitigate fibrosis. LEVEL OF EVIDENCE: NA Laryngoscope, 133:1169-1175, 2023.
引用
- Nakamura R, Bing R, Gartling GJ, et al. Glucocorticoid Dose Dependency on Gene Expression in Vocal Fold Fibroblasts and Macrophages. Laryngoscope. 2022. PMID: 36779842. doi:10.1002/lary.30330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。